IL2 and cancer: These results indicated that although unstimulated normal human T cells were significantly less sensitive to BS-181 cytotoxicity than malignant tumor cells (Jurkat A3, U937, and HeLa), PHA-stimulated normal human T cells in an interleukin-2 (IL-2)-driven rapidly proliferating state exhibited a slightly lower level of sensitivity than those of the malignant cells tested.